🕵️ Liquidia Corp ($LQDA)
SEC insider & ownership activity, last 12 months · CIK 1819576 · every row links its SEC filing
Over the last 12 months insiders sold $223.8M against $318K of open-market buying. Stephen M. Bloch sold $118.7M (Mar–Jul). 2 planned sales are pending, the largest $2.3M (Rajeev Saggar). No red-flag 8-Ks in the window.
🚨 5 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $318K (1 lots) · 15 sellers, $223.8M (174 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Stephen M. Bloch | 0 | – | 48 | $118.7M | Jul 23, 2026 |
| Jeffs Roger | 0 | – | 27 | $31.7M | Jul 13, 2026 |
| Michael Kaseta | 0 | – | 13 | $16.0M | Jul 13, 2026 |
| Paul B. Manning | 0 | – | 5 | $12.8M | Jun 4, 2026 |
| Rajeev Saggar | 0 | – | 10 | $11.2M | Aug 19, 2026 |
| Jason Adair | 0 | – | 14 | $7.8M | Aug 21, 2026 |
| Scott Moomaw | 0 | – | 11 | $5.5M | Jul 13, 2026 |
| Singh Raman | 0 | – | 5 | $4.8M | Sep 14, 2026 |
| Rielly-Gauvin Katherine | 0 | – | 2 | $4.1M | Aug 20, 2026 |
| Sarah Krepp | 0 | – | 12 | $3.7M | Sep 1, 2026 |
| Schundler Russell | 0 | – | 7 | $2.9M | Jul 13, 2026 |
| Boyle Dana | 0 | – | 13 | $2.3M | Jul 27, 2026 |
| Arthur S. Kirsch | 0 | – | 3 | $1.7M | Jun 3, 2026 |
| Caligan Partners LP | 1 | $318K | 1 | $318K | May 19, 2026 |
| Khindri Sanjeev | 0 | – | 3 | $355K | Jul 13, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11.9% | 13G | Jul 8, 2026 | filing ↗ | |
| Farallon Capital Management, L.L.C. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Joshua J. Dapice | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Dreyfuss, Philip D. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Hannah E. Dunn | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Gehani, Varun N. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Giauque, Nicolas | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Husen, Avner A. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| KIM, David T. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| LINN, Michael G. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| LUO Patrick (CHENG) | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Roberts, JR., Thomas G. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Edric C. Saito | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Daniel S. Short | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Spokes, Andrew J. M. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Warren, JOHN R. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Wehrly, MARK C. | 9.4% | 13G | Aug 4, 2026 | filing ↗ | |
| Paul B. Manning | 6.5% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Ramandeep Singh | $560K | Sep 14, 2026 | filing ↗ |
| Ramandeep Singh | $619K | Sep 11, 2026 | filing ↗ |
| Jason Adair | $5.2M | Aug 21, 2026 | filing ↗ |
| Katherine T. Rielly-Gauvin | $4.1M | Aug 19, 2026 | filing ↗ |
| Rajeev Saggar | $3.7M | Aug 19, 2026 | filing ↗ |
| Rajeev Saggar | $2.3M | Aug 17, 2026 | filing ↗ |
| Sarah Krepp | $1.6M | Jun 11, 2026 | filing ↗ |
| Canaan VIII LP | $13.0M | Jun 10, 2026 | filing ↗ |
| Canaan VIII LP | $12.8M | Jun 8, 2026 | filing ↗ |
| Canaan VIII LP | $13.0M | Jun 4, 2026 | filing ↗ |
| Paul B. Manning | $11.1M | Jun 4, 2026 | filing ↗ |
| Arthur S. Kirsch | $1.8M | Jun 1, 2026 | filing ↗ |
| Ramandeep Singh | $1.8M | May 21, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $6.4M | May 20, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $5.8M | May 14, 2026 | filing ↗ |
| Canaan VIII LP | $15.9M | May 11, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $4.2M | May 8, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $1.1M | May 7, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $2.8M | Apr 17, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $1.0M | Apr 16, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $957K | Apr 15, 2026 | filing ↗ |
| Michael Kaseta | $5.4M | Apr 15, 2026 | filing ↗ |
| Michael Kaseta | $117K | Apr 14, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $1.0M | Apr 10, 2026 | filing ↗ |
| Michael Kaseta | $960K | Apr 10, 2026 | filing ↗ |
| Serendipity Biopharma LLC | $955K | Apr 9, 2026 | filing ↗ |
| Michael Kaseta | $5.1M | Apr 9, 2026 | filing ↗ |
| Canaan VIII LP | $2.1M | Mar 27, 2026 | filing ↗ |
| Canaan VIII LP | $285K | Mar 26, 2026 | filing ↗ |
| Ramandeep Singh | $1.5M | Mar 13, 2026 | filing ↗ |
| Rajeev Saggar | $1.3M | Mar 13, 2026 | filing ↗ |
| Sarah T. Krepp | $618K | Mar 13, 2026 | filing ↗ |
| Scott Moomaw | $3.6M | Mar 9, 2026 | filing ↗ |
| Jason Adair | $1.0M | Nov 18, 2025 | filing ↗ |
| Dana Boyle | $728K | Nov 7, 2025 | filing ↗ |
| Rajeev Saggar | $1.9M | Nov 5, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Sep 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2026 | filing ↗ |
| Earnings (2.02) | Aug 12, 2026 | filing ↗ |
| Other events (8.01) | Aug 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Other events (8.01) | Jun 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Other events (8.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 27, 2025 | filing ↗ |